2023-03-01 2024-02-28 false No description of principal activity Debitam - Tax and Accounts 1.0 13230936 bus:FullAccounts 2023-03-01 2024-02-28 13230936 bus:Micro-entities 2023-03-01 2024-02-28 13230936 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 13230936 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-28 13230936 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 13230936 2023-03-01 2024-02-28 13230936 2024-02-28 13230936 bus:RegisteredOffice 2023-03-01 2024-02-28 13230936 core:WithinOneYear 2024-02-28 13230936 core:AfterOneYear 2024-02-28 13230936 2022-03-01 13230936 bus:Director1 2023-03-01 2024-02-28 13230936 bus:Director1 2024-02-28 13230936 bus:Director1 2022-03-01 2023-02-28 13230936 bus:CompanySecretary1 2023-03-01 2024-02-28 13230936 bus:LeadAgentIfApplicable 2023-03-01 2024-02-28 13230936 2022-03-01 2023-02-28 13230936 2023-02-28 13230936 core:WithinOneYear 2023-02-28 13230936 core:AfterOneYear 2023-02-28 13230936 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 13230936 core:CostValuation core:Non-currentFinancialInstruments 2024-02-28 13230936 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 13230936 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-28 13230936 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-28 13230936 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-28 13230936 core:Non-currentFinancialInstruments 2024-02-28 13230936 core:Non-currentFinancialInstruments 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13230936
England and Wales

 

 

 


Report of the Director and Unaudited Financial Statements

for the year ended 28 February 2024

for

NYX THERAPIES LTD

 
 
 
£
2024
£
   
£
2023
£
Current assets 2  2 
Creditors: amount falling due within one year (1,142) (405)
Net current assets (1,140) (403)
Total assets less current liabilities (1,140) (403)
Net assets (1,140) (403)
 
Capital and reserves (1,140) (403)
 
  1. For the year ended 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Patricia Calabro
Director

Date approved: 07 November 2024
1
Statutory Information
NYX THERAPIES LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 13230936, registration address Unit 1 393 North End Road, London, United Kingdom, SW6 1NR, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
Going Concern
The Company has discontinued the operation and the current accounts are the last set of accounts after this the directors are planning to apply for striking off the name from the registrar of the Companies.
2.

Average number of employees

Average number of employees during the year was 2  (2023: 2).
2